Full Breakdown
Anticholinergic Drugs Linked to Increased Heart Risks
3/10/2026, 12:48:39 AM
Study Overview and Findings
A recent study published in BMC Medicine has revealed a potential link between anticholinergic drugs and an increased risk of heart failure and other serious cardiac conditions. Conducted by researchers at the Karolinska Institute in Stockholm, the study found that individuals taking the highest amounts of anticholinergic medications had a 71% higher risk of developing heart health issues compared to those who did not use these drugs. The research tracked over 500,000 Stockholm residents aged 45 and older, none of whom had a prior history of heart disease, except for high blood pressure. Participants were monitored for up to 14 years to assess the long-term effects of anticholinergic drug exposure on cardiovascular health.
Mechanism of Action
Anticholinergic drugs work by inhibiting the action of acetylcholine, a neurotransmitter essential for various bodily functions. These medications are commonly used for a range of conditions, including as sleep aids, antihistamines, and treatments for urinary incontinence and certain types of depression. Notable examples include over-the-counter medications such as Tylenol PM and Advil PM, which contain diphenhydramine, an anticholinergic agent.
Implications of the Findings
While the study indicates a significant association between anticholinergic drug use and heart health risks, the researchers caution that it does not establish a direct cause-and-effect relationship. Senior researcher Hong Xu emphasized the importance of monitoring exposure to these drugs, particularly among older adults and those with multiple medical conditions. Lead investigator Nanbo Zhu noted that the cumulative burden of these medications could impact heart regulation over both short and long terms.
Criticism and Need for Further Research
The study's observational nature limits its ability to definitively link anticholinergic drugs to heart problems, as underlying health conditions in users may contribute to the observed risks. The researchers have called for clinical trials to further investigate whether these medications directly affect heart health.
Official Statements
Hong Xu stated, “Our results indicate that the cumulative drug burden can affect heart regulation, not only in the short term but also over the long term.” He added that while these drugs should not be universally avoided, careful monitoring of their use is essential.
What's Next
Future research, particularly clinical trials, will be necessary to clarify the relationship between anticholinergic drug use and cardiovascular health. The findings underscore the need for healthcare providers to evaluate the risks associated with prescribing these medications, especially for older patients.
Verbatim Quotes
- “Our results indicate that the cumulative drug burden can affect heart regulation, not only in the short term but also over the long term,” — Hong Xu, Senior Researcher, Karolinska Institute
- “We wanted to investigate whether the total exposure had any significance for the risk of developing cardiovascular disease over time.” — Nanbo Zhu, Lead Investigator, Karolinska Institute
